A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients
Phase 2
Completed
- Conditions
- Stem Cell Transplant Complications
- Interventions
- Drug: Placebo WipeDrug: Chlorhexidine Gluconate 2% Wipe
- Registration Number
- NCT03030989
- Lead Sponsor
- University of Chicago
- Brief Summary
This study evaluates the use of 2% CHG washcloths in an outpatient setting for adults after hematopoietic stem cell transplant in prevention of central line associated blood stream infections. Half of the participants will use 2% CHG washcloths and other half will use placebo washcloths.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Admitted to the University of Chicago Hematopoietic Stem Cell Transplant Unit for transplant
- Age 18 and up
Read More
Exclusion Criteria
- Experienced an allergy or rash related to use of chlorhexidine washcloths or other chlorhexidine products
- Extensive open wounds
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo wipe Placebo Wipe - Chlorhexidine Gluconate 2% Wipe Chlorhexidine Gluconate 2% Wipe -
- Primary Outcome Measures
Name Time Method Number of Participants With Primary Blood Stream Infections 14 weeks Blood stream infections are defined by the presence of bacteria in the blood
Number of Participants With Clinical (Culture-negative) Sepsis 14 weeks Clinical (culture-negative) sepsis is defined by the presence of low blood pressure without bacteria in the blood
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Chicago
🇺🇸Chicago, Illinois, United States